Your browser doesn't support javascript.
Palliative care for people who use substances during communicable disease epidemics and pandemics: a scoping review protocol.
Buchman, Daniel Z; Ding, Philip; Lo, Samantha; Dosani, Naheed; Fazelzad, Rouhi; Furlan, Andrea D; Isenberg, Sarina R; Spithoff, Sheryl; Tedesco, Alissa; Zimmermann, Camilla; Lau, Jenny.
  • Buchman DZ; Bioethics, Centre for Addiction and Mental Health, Toronto, Ontario, Canada daniel.buchman@utoronto.ca.
  • Ding P; Clinical Public Health, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Lo S; Joint Centre for Bioethics, University of Toronto, Toronto, Ontario, Canada.
  • Dosani N; Department of Supportive Care, University Health Network, Toronto, Ontario, Canada.
  • Fazelzad R; Department of Supportive Care, University Health Network, Toronto, Ontario, Canada.
  • Furlan AD; Department of Medicine, Unity Health Toronto, Toronto, Ontario, Canada.
  • Isenberg SR; Inner City Health Associates, Toronto, Ontario, Canada.
  • Spithoff S; Library and Information Services, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Tedesco A; Toronto Rehab, University Health Network, Toronto, Ontario, Canada.
  • Zimmermann C; Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Lau J; Institute for Work & Health, University Health Network, Toronto, Ontario, Canada.
BMJ Open ; 11(10): e053124, 2021 10 27.
Article in English | MEDLINE | ID: covidwho-1495470
ABSTRACT

INTRODUCTION:

Communicable disease epidemics and pandemics magnify the health inequities experienced by marginalised populations. People who use substances suffer from high rates of morbidity and mortality and should be a priority to receive palliative care, yet they encounter many barriers to palliative care access. Given the pre-existing inequities to palliative care access for people with life-limiting illnesses who use substances, it is important to understand the impact of communicable disease epidemics and pandemics such as COVID-19 on this population. METHODS AND

ANALYSIS:

We will conduct a scoping review and report according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews reporting guidelines. We conducted a comprehensive literature search in seven bibliographical databases from the inception of each database to August 2020. We also performed a grey literature search to identify the publications not indexed in the bibliographical databases. All the searches will be rerun in April 2021 to retrieve recently published information because the COVID-19 pandemic is ongoing at the time of this writing. We will extract the quantitative data using a standardised data extraction form and summarise it using descriptive statistics. Additionally, we will conduct thematic qualitative analyses and present our findings as narrative summaries. ETHICS AND DISSEMINATION Ethics approval is not required for a scoping review. We will disseminate our findings to healthcare providers and policymakers through professional networks, digital communications through social media platforms, conference presentations and publication in a scientific journal.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Communicable Diseases / COVID-19 Type of study: Prognostic study / Qualitative research / Randomized controlled trials / Reviews Limits: Humans Language: English Journal: BMJ Open Year: 2021 Document Type: Article Affiliation country: Bmjopen-2021-053124

Full text: Available Collection: International databases Database: MEDLINE Main subject: Communicable Diseases / COVID-19 Type of study: Prognostic study / Qualitative research / Randomized controlled trials / Reviews Limits: Humans Language: English Journal: BMJ Open Year: 2021 Document Type: Article Affiliation country: Bmjopen-2021-053124